Skip to main content

Advertisement

Table 1 Demographic, clinical, and treatment characteristics of included patients

From: Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

Characteristics Total Placebo Gentamicin/Placebo Gentamicin
  n = 15 n = 5 n = 4 n = 5
Sex     
Male 8 (53%) 1 (20%) 4 (100%) 3 (60%)
Age (mean, (SD)) 64.8 (12.5) 57.3 (16.7) 72.6 (5) 64.5 (8)
Duration of MD in years (median (range)) 3 (0.1-19.6) 2.5 (0.1-18.2) 3.3 (0.7-7.5) 3.1 (1.1-19.6)
DHI 48.6 (20.0) 54.0 (18.0) 40.5 (16.4) 51.2 (25.5)
Averaged (0.5, 1, 2, 4 kHz) pure-tone-hearing loss (dB HL)     
Right 41.2 (19.9) 35.0 (24.5) 29.7 (7.4) 59.0 (8.6)
Left 50.6 (23.7) 43.8 (21.6) 61.3 (30.7) 46.8 (21.3)